Skip to content

Companies3 min read

HEALWELL Buys Fredericton's VeroSource for Up to $24.5M

The digital-health interoperability company behind provincial patient-access software joined TSX-listed HEALWELL AI in July 2024 — $19.6M upfront plus an earn-out of up to $4.9M.

A Fredericton health-software block sliding into a larger health AI platform, with readouts of $19.6 million upfront and up to $4.9 million earn-out

Fredericton’s clearest digital-health exit of 2024 did not come from a campus cybersecurity lab. It came from the software that helps provincial systems open a digital front door.

On July 1–2, 2024, Toronto-listed HEALWELL AI (TSX: AIDX) closed its acquisition of VeroSource Solutions — a Fredericton-founded interoperability and patient-access platform. Consideration was $19.6 million plus a four-year performance earn-out of up to $4.9 million, matching the ~$24.5 million package HEALWELL had announced in June.

What HEALWELL bought

VeroSource, founded in 2014, builds cloud software that connects patients, clinicians, and administrators to health data — EMRs, pharmacies, hospital systems — and layers analytics on top. HEALWELL’s announcement said the company already served five provincial health clients, had logged well over one million patient and provider users since inception, and was expected to generate more than $8 million in 2024 revenue with mostly recurring sales.

The product story HEALWELL emphasized is public-sector plumbing: digital front door / patient access, FHIR interoperability, international patient summary tools, and digital identity — plus applied AI experiments such as ER wait-time prediction from live HL7 feeds. New Brunswick is named explicitly among the provincial customers in the June release.

The deal shape

HEALWELL originally pitched a two-step buy (51% then the rest). On June 28, 2024, the parties amended the agreement to take 100% at once for the same total consideration. The closing release breaks the $19.6 million into cash, HEALWELL subordinate voting shares, a promissory note, and the earn-out tied to VeroSource EBITDA growth.

CEO Mark McAllister framed the sale as scale: join HEALWELL to push digital-health products across Canada faster. For HEALWELL CEO Dr. Alexander Dobranowski, VeroSource was the enterprise data layer that could carry population-health AI into provincial systems.

What the price tells you about the business

The multiple is the most informative number in the release. Against expected 2024 revenue of more than $8 million, a headline package of roughly $24.5 million works out to around three times revenue — modest for health software, and a fair reflection of what VeroSource was: a government-contract business with recurring revenue, high switching costs, and a ceiling set by how many provinces exist.

That is the trade in a public-sector software company. Provincial contracts are extraordinarily sticky — a health authority does not re-tender its patient-access layer casually — and the revenue is predictable enough to underwrite a purchase price. But the sales cycle is measured in years, the buyer pool is ten provinces and three territories, and nobody is going to pay a growth multiple for a company whose total addressable market is a list you can write from memory. Five provincial clients out of ten possible is simultaneously impressive penetration and a visible limit.

The deal shape reflects that too. HEALWELL first structured it as a two-step purchase — 51%, then the rest — before amending to take 100% at once for the same total. Buying in stages is what an acquirer does when it wants to see the numbers hold before committing; collapsing the steps suggests it stopped needing to.

Where it left Fredericton

The part that matters locally is what did not move. VeroSource remained an operating unit with a Fredericton centre of gravity rather than being absorbed into Toronto, and HEALWELL's subsequent filings continue to list it as an operating Healthcare Software business.

That outcome is not automatic and is worth not over-reading. An acquirer keeps engineering where the institutional knowledge is, and for a company whose product is wired into a specific province's health systems, the knowledge and the province are the same place. The retention is a function of the contracts as much as of goodwill — which is a more durable reason for the jobs to stay than a promise in a press release, and a less flattering one.

What VeroSource still does with those contracts is the MyHealthNB story: the assembly layer behind a patient app most New Brunswickers use without knowing the vendor's name.

Sources

Related coverage